Issue link: https://beckershealthcare.uberflip.com/i/1156517
65 HEALTHCARE NEWS Highest-paid CEOs in 2018: Who made the list from healthcare By Emily Rappleye T hirty-two healthcare CEOs made e New York Times and Equilar's 2018 ranking of highest-paid CEOs in 2018. Of those 32, three executives led some of the nation's largest for-profit hospital systems: King of Prussia, Pa.-based Universal Health Services, Nashville, Tenn.-based HCA Healthcare and Dallas-based Tenet Health- care. e full list includes 200 chief execu- tives from public companies with revenue of at least $1 billion. Here are the 32 healthcare companies and CEOs that made the list, in order of total compensation in 2018. Total compensation may include salary, bonuses, perks, stock and options. 1. Hologic, Stephen MacMillan — $42 million 2. Align Technology, Joseph Hogan — $42 million 3. Regeneron Pharmaceuticals, Leonard Schleifer — $27 million 4. Centene, Michael Neidorff — $26 million 5. Universal Health Services, Alan Miller — $24 million 6. Abbott Laboratories, Miles White — $23 million 7. CVS Health, Larry Merlo — $22 million 8. Merck, Kenneth Frazier — $21 million 9. Abbvie, Richard Gonzalez — $21 million 10. Johnson & Johnson, Alex Gorsky — $20 million 11. HCA Healthcare, R. Milton Johnson — $20 million 12. Pfizer, Ian Read — $20 million 13. Bristol-Myers Squibb, Giovanni Caforio — $19 million 14. Cigna, David Cordani — $19 million 15. Vertex Pharmaceuticals, Jeffrey Leiden — $19 million 16. ermo Fisher Scientific, Marc Casper — $19 million 17. Amgen, Robert Bradway — $19 million 18. UnitedHealth Group, David Wichmann — $18 million 19. DaVita, Kent iry — $17 million 20. Gilead Sciences, John Milligan — $17 million 21. Alexion Pharmaceuticals, Ludwig Hant- son — $16 million 22. Humana, Bruce Broussard — $16 million 23. Celgene, Mark Alles — $16 million 24. Biogen, Michel Vounatsos — $16 million 25. United erapeutics, Martine Rothblatt — $16 million 26. IQVIA Holdings, Ari Bousbib — $16 million 27. Eli Lilly, David Ricks — $16 million 28. Baxter International, José Almeida — $16 million 29. Biomarin Pharmaceutical, Jean-Jacques Bienaimé — $16 million 30. Danaher, omas Joyce Jr. — $15 million 31. Molina Healthcare, Joseph Zubretsky — $15 million 32. Tenet Healthcare, Ron Rittenmeyer — $15 million n Beaumont's CIN to terminate agreement with 2,500-member physician group By Morgan Haefner B eaumont Care Partners, the clinically integrated network of Southfield, Mich.-based Beaumont Health, will end its agreement with United Physi- cians, a roughly 2,500-member group also based in Michigan, accord- ing to Crain's Detroit Business. Beaumont's CIN, which is made up of Beaumont's eight hospitals and roughly 4,300 affiliated physicians, voted out United Physicians after the group failed to pay $800,000 in capital payments during the last two years, according to the report. United Physicians President Mike Williams, MD, told Crain's the organization withheld payments because the founding principles of the CIN were not being upheld. One-third of United Physi- cians' members are employed by Beaumont and continue to be employed by Beaumont even though United Physicians is no longer part of Beaumont Care Partners. Dr. Williams also told Crain's the motion to terminate the agreement during the CIN's mid-April meeting was unexpected and came from Beaumont CMO David Wood, MD. Beaumont Health and Beaumont ACO voted to remove United Physicians from the CIN without discussion, according to Dr. Williams. John Fox, CEO of Beaumont, told Crain's that a number of physicians had ex- pressed frustration with the late capital payments. Beaumont officials also told the publication that United Physicians didn't comply with decisions to grow the CIN through more payer and employer contracts. While United Physicians will no longer be a part of Beaumont Care Partners, individual physicians within United Physicians will still care for Beaumont pa- tients under the CIN's contracts covering about 60,000 lives, according to the report. n